Abstract
Cyclosporin A (CyA) is an immunosuppressive agent which has been used in children following kidney transplantation since 1982. The paediatric experience made with CyA in a single centre is reported here. Forty-seven children, ranging in age from 2 to 16 years, were given transplants between September 1982 and May 1986 and received CyA with low-dose prednisolone for immunosuppression. The mean cold ischaemia time of the grafts was 20.9 h. Under routine volume expansion during and 24 h post-transplantation, 40 grafts (85%) functioned immediately. Acute rejection episodes occurred with the highest frequency during the 1st month (0.6 rejection/patient). The actuarial surival rate for patients was 98% after 3 years. Graft survival was 92% after 1 year, 87% after 2 years and 78% after 3 years. The side-effects observed with CyA were hypertrichosis (38%), neurological complications (21%), and infections (17%). One girl of 16 years developed benign mammary fibroadenomas. Hypertension was common (60%), but less so than seen with conventional therapy (83%). Graft function was reduced. The mean creatinine clearance at 6 weeks after transplantation was 60 ml/min per 1.73 m2, after 1 year was 46.4 ml/min per 1.73 m2 and after 2 years it was 42.5 ml/min per 1.73 m2. Twenty-nine children with functioning grafts of at least 1 year could be evaluated for growth performance and normal or even catch-up growth could be demonstrated for the whole group. The individual annual growth rates expressed by standard deviation score (SDS) remained stable or even improved 3 years after kidney transplantation. Longer periods of follow-up are necessary to confirm whether the advantages concerning survival rates and growth rates persist over time and will outweigh the side-effects of CyA treatment.
Similar content being viewed by others
References
Fine RN, Malekzadeh MH, Pennisi AJ, Ettenberger RB, Uittenbogaart CH, Negrete VF, Korsch BM (1978) Long term results of renal transplantation in children. Pediatrics 61: 641
Pichlmayr R, Brodehl J, Offner G, Tidow G (1982) Klinische Probleme und Ergebnisse der Nierentransplantation beim Kind. Med Klinik 77: 79–82
Grushkin CM, Fine RN (1973) Growth in children following renal transplantation. Am J Dis Child 125: 514–516
Offner G, Brandis M, Brodehl J, Krohn HP, Pichlmayr R, Tidow G (1979) Nierentransplantation bei Kindern in Hannover 1970–1977. Dtsch Med Wochenschr 104: 393–401
Gradus D, Ettenger RB (1982) Renal transplantation in children. Pediatr Clin N Am 29: 1013–1038
Borel JF, Feurer C, Magnee C, Stahelin H (1977) Effects of the new antilymphocytic peptide cyclosporine A in animals. Immunology 32: 1017–1025
Calne RY, White DJG, Thirn S, Evans DB, McMaster P, Dunn DC, Craddock GH, Pentlow BD, Rolles K (1978) Cyclosporine A in patients receiving renal allografts from cadaver donors. Lancet II: 1323–1327
Calne RY, Rolles K, White DJG, Thira S, Evans DB, McMaster P, Dunn DC, Craddock GH, Henderson RG, Aziz S, Lewis P (1979) Cyclosporine A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers. Lancet II: 1033–1036
European Multicenter Trial Group (1983) Cyclosporine in cadaveric renal transplantation: one year follow up of a multi-centre trial. Lancet II: 986–989
Canadian Multicenter Transplant Study Group (1983) A randomized clinical trial of cyclosporine in cadaveric renal transplantation. N Engl J Med 309: 809–815
Conley SB, Brewer ED, Flechner SM, Van Buren CT, Kahan BD (1983) Renal transplantation using cyclosporine in pediatric patients 3 to 17 years old. Transplant Proc 15: 2528–2530
Klare B, v. Walter J, Hahn H, Emmerich P, Land W (1984) Cyclosporine in renal transplantation in children. Lancet II: 692
Bunzendahl H, Offner G, Wonigeit K, Brodehl J, Pichlmayr R (1984) Cyclosporine treatment in paediatric kidney transplantation. In: Brodehl J, Ehrich JHH (eds) Paediatric nephrology. Springer Berlin Heidelberg New York, pp 154–157
Hoyer PF, Offner G, Wonigeit K, Brodehl J, Pichlmayr R (1984) Dosage of cyclosporine A in children with renal transplants. Clin Nephrol 22: 68–71
Cohen DJ, Loertscher R, Rubin MF, Tilney NL, Carpenter CB, Strom TB (1984) Cyclosporine: a new immunosuppressive agent for organ transplantation. Ann Intern Med 101: 667–682
Wood AJ, Maurer G, Niederberger W, Beveridge T (1983) Cyclosporine: pharmacokinetics, metabolism and drug interactions. Transplant Proc 15: 2409–2412
Donatsch P, Albioch E, Homberger M, Traber R, Trapp M, Voges R (1981) A radioimmunoassay to measure cyclosporine A in plasma and serum samples. J Immunoassay 2: 19–32
Carlier M, Squifflet JP, Pirson Y, Gribomont B, Alexandre GPJ (1982) Maximal hydration during anesthesia increases pulmonary arterial pressures and improves early function of human renal transplants. Transplantation 34: 201–204
Hoyer PF, Offner G, Brodehl J (1983) Acute rejection episodes after renal transplantation in children. Clin Nephrol 19: 61–66
Ingelfinger JR (1982) Pediatric hypertension. W. B. Saunders, Philadelphia, pp 255–268
Brodehl J, Pichlmayr R, Offner G (1985) 14 Jahre Nieren-transplantation bei Kindern. Ergebnisse mit besonderer Berücksichtigung der Cyclosporin-A-Behandlung. Monatsschr Kinderheilkd 133: 771–773
Hoyer PF, Krohn HP, Offner G, Byrd DJ, Brodehl J, Wonigeit K, Pichlmayr R (1986) Renal function after kidney transplantation in children: a comparison of conventional immunosuppression with Cyclosporine A. Transplantation (in press)
Schwartz GJ, Haycock GB, Edelmann CM jr, Spitzer A (1976) A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 58: 259–263
Tanner JM, Whitehouse RH (1976) Clinical longitudinal standards of height, weight, height velocity, weight velocity and stages of puberty. Arch Dis Child 51: 170–179
Tanner JM, Whitehouse RH, Hughes PCR, Vince FP (1971) Effects of human growth hormone treatment of 1 to 7 years on growth of 100 children with growth hormone deficiency, low birth weight, inherited smallness, Turner's syndrome and other complaints. Arch Dis Child 46: 745–782
Merion RM, White DJG, Thiru S, Evans DB, Calne RY (1984) Cyclosporin: five years experience in cadaveric renal transplantation. N Engl J Med 310: 148–154
Brodehl J, Offner G, Hoyer PF, Schirg E, Pichlmayr R, Wonigeit K (1986) Cyclosporin in pediatric kidney transplantation and its effect on post-transplantation. Nephron 44: 26–31
Brodehl J, Offner G, Hoyer PF (1986) La cyclosporine A en transplantation renale pediatrique. Actualites nephrologiques. Flammarion, Paris, pp 331–343
Flechner SM, Conley SB, Van Buren CT, Rose G, Kerman R, Kohan BD (1985) Impact of Cyclosporine on renal function and growth in pediatric renal transplant recipients. Transplant Proc 17: 1284–1288
Tejani A, Butt K, Trachtmann H, Phadke K, Adamson O (1985) Cyclosporin as the sole maintenance immunosuppression in children with renal transplants. Kidney Int 27: 350
Conley SB, Flechner SM, Rose G, Van Buren CT, Brewer ED, Kahan BD (1985) Use of cyclosporin in pediatric renal transplant recipients. J Pediatr 106: 45–49
Starzl TE, Iwatsuki S, Malatack JJ, Zitelli BJ, Gartner JC, Hakala TR, Rosenthal JT, Shaw BW (1982) Liver and kidney transplantation in children receiving cyclosporin A and steroids. J Pediatr 100: 681–686
Knight JF, Roy LP, Sheil AGR (1985) Catch-up growth in children with successful renal transplants immunosuppressed with cyclosporin alone. Lancet I: 159–160
Pennisi AJ, Costin G, Phillips LS, Uittenbogaart G, Ettenger RB, Malekzadeh MH, Fine RN (1977) Linear growth in long-term renal allograft recipients. Clin Nephrol 8: 415–412
Bosque M, Munian A, Bewick M, Haycock G, Chantler C (1983) Growth after renal transplants. Arch Dis Child 58: 110–114
Ellis D, Avner ED, Rosenthal JT, Taylor RJ, Young LW, Palunbi MA, Hakala TR (1985) Renal function and somatic growth in pediatric cadaveric renal transplantation with Cyclosporine — prednisone immunosuppression. Am J Dis Child 139: 1161–1167
Chapman JR, Harding NGL, Griffiths D, Morris PJ (1985) Reversibility of cyclosporin nephrotoxicity after three months of treatment. Lancet I: 128–130
Klintmalm G, Bohman SO, Sundelin B, Wilczek H (1984) Interstitial fibrosis in renal allografts after 12 to 46 months of cyclosporin treatment: beneficial effects of low doses in early post-transplantation period. Lancet II: 950–954
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Offner, G., Hoyer, P.F., Brodehl, J. et al. Cyclosporin A in paediatric kidney transplantation. Pediatr Nephrol 1, 125–130 (1987). https://doi.org/10.1007/BF00849281
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00849281